Curaleaf Holdings (CURLF) Interest Expenses (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Interest Expenses of -$14.4 million in Q3 2025, up 1.84% quarter-over-quarter from -$14.6 million in Q2 2025, and up 4.7% on a YoY basis from -$13.7 million in Q3 2024.
Curaleaf Holdings (CURLF) Interest Expenses (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at -$14.4 million for Q3 2025.
- In Q3 2025, Interest Expenses rose 4.7% year-over-year to -$14.4 million; the TTM figure through Mar 2026 stood at -$29.0 million (up 34.1% YoY), while the FY2022 annual figure was -$17.3 million, up 67.02% from the prior year.
- Interest Expenses was -$14.4 million for Q3 2025 at Curaleaf Holdings, up from -$14.6 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of -$10.0 million in Q1 2023 to a low of -$17.4 million in Q4 2022.
- Historically, Interest Expenses has averaged -$14.2 million across 5 years, with a median of -$14.4 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses climbed 28.09% in 2023, then slumped 53.71% in 2024.
- A 5-year view of Interest Expenses shows it stood at -$13.1 million in 2021, then slumped by 33.04% to -$17.4 million in 2022, then increased by 25.0% to -$13.1 million in 2023, then fell by 15.35% to -$15.1 million in 2024, then climbed by 4.7% to -$14.4 million in 2025.
- The last three Interest Expenses figures came in at -$14.4 million (Q3 2025), -$14.6 million (Q2 2025), and -$14.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 4.86 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -14.38 Mn |
| Sep 30, 2025 | -14.38 Mn |
| Jun 30, 2025 | -14.65 Mn |
| Jun 30, 2025 | -14.65 Mn |
| Mar 31, 2025 | -14.16 Mn |
| Mar 31, 2025 | -14.16 Mn |
| Sep 30, 2024 | -15.09 Mn |
| Sep 30, 2024 | -15.09 Mn |
| Jun 30, 2024 | -14.79 Mn |
| Jun 30, 2024 | -14.79 Mn |
| Mar 31, 2024 | -15.36 Mn |
| Mar 31, 2024 | -15.36 Mn |
| Sep 30, 2023 | -13.08 Mn |
| Sep 30, 2023 | -13.08 Mn |
| Jun 30, 2023 | -17.06 Mn |
| Jun 30, 2023 | -17.06 Mn |
| Mar 31, 2023 | -10.00 Mn |
| Mar 31, 2023 | -10.00 Mn |
| Dec 31, 2022 | -17.44 Mn |
| Dec 31, 2022 | -17.44 Mn |